Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-QUETIAPINE | 300MG | TABLET | Resolved | 2021-05-14 | 2021-06-07 | 139419 |
APO-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-14 | 2021-06-21 | 139422 |
APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2021-05-14 | 2021-06-21 | 139425 |
APO-DONEPEZIL | 5MG | TABLET | Resolved | 2021-05-25 | 2021-08-06 | 139834 |
APO-FLUCONAZOLE-150 | 150MG | CAPSULE CAPSULE | Resolved | 2021-05-25 | 2021-09-20 | 139837 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2021-05-25 | 2021-07-15 | 139842 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-05-25 | 2021-10-05 | 139845 |
APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-25 | 2021-07-22 | 139848 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-25 | 2021-06-28 | 139851 |
APO-VARDENAFIL | 5MG | TABLET | Resolved | 2021-05-25 | 2021-11-01 | 139854 |
APO-VARDENAFIL | 10MG | TABLET | Resolved | 2021-05-25 | 2021-11-02 | 139857 |
APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140066 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140069 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2021-05-28 | 2021-06-28 | 140072 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-05-28 | 2021-07-09 | 140075 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-05-28 | 2021-07-30 | 140078 |
APO-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-06-04 | 2021-06-28 | 140414 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-06-04 | 2021-06-14 | 140417 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-06-04 | 2021-06-22 | 140420 |
APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-04 | 2021-06-14 | 140423 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |